Plain-English translation of NCT07270991 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether combining two oral medications— and —works better than alone for people with advanced stomach cancer that has spread or stopped responding to earlier treatments. is designed to cut off the blood supply that tumors need to grow, and researchers hope combining it with the medication may help patients live longer.
Advanced stomach cancer is very difficult to treat, and current third-line treatments only extend survival by a few months. Because stomach tumors rely on developing new blood vessels to survive, researchers believe that combining this medication with a drug that blocks blood vessel formation may offer better results.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you will be randomly assigned to receive either alone or combined with . Both are oral medications you take by mouth on a repeating 28-day cycle. You will take on days 1–5 and days 8–12 of each cycle; if you are in the combination group, you will also take daily for the first 21 days of each cycle. Treatment continues until your cancer progresses, you experience unacceptable side effects, or you decide to stop.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
France